Medytox Inc.
SEC CIK 1848514 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EOLS | Evolus, Inc. | Former 10% Owner | 3.38M | $8.06M | $33.81M | 16 | 2021-08-11 | 2023-10-16 |
Most active insiders at EOLS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MOATAZEDI DAVID | See Remarks, Dir | — | $1.66M |
| 2 | Avelar Rui | See Remarks | — | $177.7K |
| 3 | Mitchell Tatjana | CFO | — | — |
| 4 | Stewart Brady | Dir | — | — |
| 5 | Malik Vikram | Dir | — | — |
| 6 | Parschauer Karah Herdman | Dir | — | — |
| 7 | White Albert G III | Dir | — | — |
| 8 | GILL DAVID N | Dir | — | — |
Medytox Inc. made no open-market trades at EOLS in the last 12 months.
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-18 | 2023-10-16 | EOLS | Evolus, Inc. | Medytox Inc. | Former 10% Owner | S - Sale | $7.50 | -1.69M | 3.38M | -33% | -$12.68M | |
| 2023-02-08 | 2023-02-07 | EOLS | Evolus, Inc. | Medytox Inc. | 10% | S - Sale | $8.50 | -2.19M | 5.07M | -30% | -$18.59M | |
| MI | 2023-02-06 | 2021-08-12+ | EOLS | Evolus, Inc. | Medytox Inc. | 10% | P - Purchase | $11.04 | +37.0K | 7.30M | +0.5% | +$408.8K |
| I | 2023-02-06 | 2023-01-20 | EOLS | Evolus, Inc. | Medytox Inc. | 10% | S - Sale | $11.04 | -37.0K | 7.26M | -0.5% | -$409.0K |
| 2022-10-07 | 2022-10-06 | EOLS | Evolus, Inc. | Medytox Inc. | 10% | S - Sale | $8.99 | -38.3K | 7.26M | -0.5% | -$344.4K | |
| 2022-10-06 | 2022-10-05 | EOLS | Evolus, Inc. | Medytox Inc. | 10% | S - Sale | $8.95 | -6,848 | 7.30M | -0.1% | -$61.3K | |
| M | 2022-09-16 | 2022-09-14+ | EOLS | Evolus, Inc. | Medytox Inc. | 10% | S - Sale | $10.29 | -97.0K | 7.30M | -1% | -$997.9K |
| M | 2022-09-12 | 2022-09-08+ | EOLS | Evolus, Inc. | Medytox Inc. | 10% | S - Sale | $10.47 | -36.0K | 7.40M | -0.5% | -$376.9K |
| 2022-08-03 | 2022-08-01 | EOLS | Evolus, Inc. | Medytox Inc. | 10% | S - Sale | $13.28 | -26.0K | 7.44M | -0.3% | -$345.3K | |
| 2021-08-31 | 2021-08-27 | EOLS | Evolus, Inc. | Medytox Inc. | 10% | P - Purchase | $10.93 | +51.0K | 7.46M | +0.7% | +$557.4K | |
| M | 2021-08-27 | 2021-08-25+ | EOLS | Evolus, Inc. | Medytox Inc. | 10% | P - Purchase | $11.06 | +110.0K | 7.41M | +2% | +$1.22M |
| M | 2021-08-25 | 2021-08-23+ | EOLS | Evolus, Inc. | Medytox Inc. | 10% | P - Purchase | $11.10 | +142.0K | 7.30M | +2% | +$1.58M |
| M | 2021-08-23 | 2021-08-19+ | EOLS | Evolus, Inc. | Medytox Inc. | 10% | P - Purchase | $10.53 | +103.0K | 7.11M | +1% | +$1.08M |
| M | 2021-08-19 | 2021-08-17+ | EOLS | Evolus, Inc. | Medytox Inc. | 10% | P - Purchase | $10.63 | +115.0K | 7.01M | +2% | +$1.22M |
| M | 2021-08-17 | 2021-08-13+ | EOLS | Evolus, Inc. | Medytox Inc. | 10% | P - Purchase | $11.18 | +114.7K | 6.88M | +2% | +$1.28M |
| M | 2021-08-13 | 2021-08-11+ | EOLS | Evolus, Inc. | Medytox Inc. | 10% | P - Purchase | $10.87 | +65.3K | 6.79M | +1.0% | +$709.4K |
Purchase Sale Sale after option exercise All abbreviations